Zanoni Paolo, Khetarpal Sumeet A, Larach Daniel B, Hancock-Cerutti William F, Millar John S, Cuchel Marina, DerOhannessian Stephanie, Kontush Anatol, Surendran Praveen, Saleheen Danish, Trompet Stella, Jukema J Wouter, De Craen Anton, Deloukas Panos, Sattar Naveed, Ford Ian, Packard Chris, Majumder Abdullah al Shafi, Alam Dewan S, Di Angelantonio Emanuele, Abecasis Goncalo, Chowdhury Rajiv, Erdmann Jeanette, Nordestgaard Børge G, Nielsen Sune F, Tybjærg-Hansen Anne, Schmidt Ruth Frikke, Kuulasmaa Kari, Liu Dajiang J, Perola Markus, Blankenberg Stefan, Salomaa Veikko, Männistö Satu, Amouyel Philippe, Arveiler Dominique, Ferrieres Jean, Müller-Nurasyid Martina, Ferrario Marco, Kee Frank, Willer Cristen J, Samani Nilesh, Schunkert Heribert, Butterworth Adam S, Howson Joanna M M, Peloso Gina M, Stitziel Nathan O, Danesh John, Kathiresan Sekar, Rader Daniel J
Departments of Genetics and Medicine, Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Departments of Genetics and Medicine, Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. INSERM UMR 1166 ICAN, Université Pierre et Marie Curie Paris 6, Hôpital de la Pitié, Paris, France.
Science. 2016 Mar 11;351(6278):1166-71. doi: 10.1126/science.aad3517.
Scavenger receptor BI (SR-BI) is the major receptor for high-density lipoprotein (HDL) cholesterol (HDL-C). In humans, high amounts of HDL-C in plasma are associated with a lower risk of coronary heart disease (CHD). Mice that have depleted Scarb1 (SR-BI knockout mice) have markedly elevated HDL-C levels but, paradoxically, increased atherosclerosis. The impact of SR-BI on HDL metabolism and CHD risk in humans remains unclear. Through targeted sequencing of coding regions of lipid-modifying genes in 328 individuals with extremely high plasma HDL-C levels, we identified a homozygote for a loss-of-function variant, in which leucine replaces proline 376 (P376L), in SCARB1, the gene encoding SR-BI. The P376L variant impairs posttranslational processing of SR-BI and abrogates selective HDL cholesterol uptake in transfected cells, in hepatocyte-like cells derived from induced pluripotent stem cells from the homozygous subject, and in mice. Large population-based studies revealed that subjects who are heterozygous carriers of the P376L variant have significantly increased levels of plasma HDL-C. P376L carriers have a profound HDL-related phenotype and an increased risk of CHD (odds ratio = 1.79, which is statistically significant).
清道夫受体BI(SR-BI)是高密度脂蛋白(HDL)胆固醇(HDL-C)的主要受体。在人类中,血浆中高水平的HDL-C与较低的冠心病(CHD)风险相关。Scarb1基因缺失的小鼠(SR-BI基因敲除小鼠)血浆HDL-C水平显著升高,但矛盾的是,动脉粥样硬化却加重了。SR-BI对人类HDL代谢和CHD风险的影响仍不清楚。通过对328名血浆HDL-C水平极高的个体的脂质修饰基因编码区进行靶向测序,我们在编码SR-BI的基因SCARB1中鉴定出一个功能丧失变体的纯合子,其中第376位脯氨酸被亮氨酸取代(P376L)。P376L变体损害SR-BI的翻译后加工,并消除转染细胞、来自该纯合子个体诱导多能干细胞的类肝细胞以及小鼠中的选择性HDL胆固醇摄取。基于大量人群的研究表明,P376L变体的杂合子携带者血浆HDL-C水平显著升高。P376L携带者具有明显的HDL相关表型,且CHD风险增加(优势比=1.79,具有统计学意义)。